RankingsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Revenue

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥188.4B
P/E ratio
67.5x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202594,035+30.52%
Mar 31, 202472,044-1.29%
Mar 31, 202372,984-4.01%
Mar 31, 202276,034+1.41%
Mar 31, 202174,979-15.97%
Mar 31, 202089,232-5.24%
Mar 31, 201994,165-4.33%
Mar 31, 201898,430-3.00%
Mar 31, 2017101,479-7.52%
Mar 31, 2016109,730+16.87%
Mar 31, 201593,889+5.56%
Mar 31, 201488,946+2.17%
Mar 31, 201387,054-1.07%
Mar 31, 201287,997

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)